Physicians’ opposition even with extension of indications on ‘Daklinza’
Medical personnel have expressed opposition to the fact that the indication for genotype 2 was excluded from ‘Daklinza(generic name: daclatasvir)’ during the process of extending indications.
Recently, the Ministry of Food and Drug Safety approved to change the Daklinza’s indication from ‘treatm...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
